CODX (Co-Diagnostics, Inc. Common Stock) Stock Analysis - SEC Filings

Co-Diagnostics, Inc. Common Stock (CODX) is a publicly traded Healthcare sector company. As of May 21, 2026, CODX trades at $3.29 with a market cap of $4.94M and a P/E ratio of -0.06. CODX moved +21.32% today. Year to date, CODX is -58.36%; over the trailing twelve months it is -71.03%. Its 52-week range spans $1.26 to $46.50. Rallies surfaces CODX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find CODX SEC filings?

Rallies organizes CODX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

CODX Key Metrics

Key financial metrics for CODX
MetricValue
Price$3.29
Market Cap$4.94M
P/E Ratio-0.06
EPS$-39.08
Dividend Yield0.00%
52-Week High$46.50
52-Week Low$1.26
Volume3.11M
Avg Volume0
Revenue (TTM)$718.17K
Net Income$-48.50M
Gross Margin45.06%

Latest CODX News

CODX Analyst Consensus

CODX analyst coverage data. Average price target: $0.00.

Common questions about CODX

Where can I find CODX SEC filings?
Rallies organizes CODX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show CODX 10-K and 10-Q filings?
Rallies organizes CODX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is CODX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CODX. It does not provide personalized investment advice.
CODX

CODX